Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Anti-Dyskinesia Agents

"Anti-Dyskinesia Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

Drugs used in the treatment of movement disorders. Most of these act centrally on dopaminergic or cholinergic systems. Among the most important clinically are those used for the treatment of Parkinson disease (ANTIPARKINSON AGENTS) and those for the tardive dyskinesias.


This graph shows the total number of publications written about "Anti-Dyskinesia Agents" by people in Harvard Catalyst Profiles by year, and whether "Anti-Dyskinesia Agents" was a major or minor topic of these publication.
Bar chart showing 21 publications over 13 distinct years, with a maximum of 4 publications in 2006
To see the data from this visualization as text, click here.
Related Networks
People
Explore
_
Similar Concepts
_
Top Journals 
_
Funded by the NIH/NCATS Clinical and Translational Science Award (CTSA) program, grant number UL1TR001102, and through institutional support from Harvard University, Harvard Medical School, Harvard T.H. Chan School of Public Health, Beth Israel Deaconess Medical Center, Boston Children's Hospital, Brigham and Women's Hospital, Massachusetts General Hospital and the Dana Farber Cancer Institute.